Edaravone dexborneol sublingual tablet

DRUG2 trials

Sponsors

Simcere Pharmaceutical Co., Ltd, Xinqiao Hospital of Chongqing

Conditions

Acute Ischemic StrokePost-stroke Cognitive Impairment

Phase 2

Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients

RecruitingNCT06315231

Simcere Pharmaceutical Co., LtdPost-stroke Cognitive Impairment

Start: 2024-04-08End: 2026-12-30Target: 226Updated: 2025-09-03

Phase 4

Sublingual Edaravone Dexborneol for Inter-hospital Transfer Acute Ischemic Stroke (SLEDAIS)

Not yet recruitingNCT07682922

Xinqiao Hospital of ChongqingAcute Ischemic Stroke

Start: 2026-07-01End: 2028-09-30Target: 1040Updated: 2026-07-06